Re: Coronavirus
Quote:
Quote:
The EU is a political construct that continues to extend and deepen its influence over its members thanks to the basic assumption that a concept they call “pooled sovereignty” is better than nation states acting for themselves. The UK has in this case been able to act in a more agile manner than the sclerotic EU bureaucracy to get vaccine approval and distribution going earlier and at a faster rate. It has leveraged long-standing policies that have continued to encourage world-leading research to happen here as well as high-tech manufacturing. Part of the package here is attracting the highly educated and talented individuals to come here to do their research and development and to work in these cutting-edge manufacturing processes - wherever in the world they come from. I have no desire to turn the coronavirus thread into another Brexit/EU thread, but not do I have any intention of allowing such a glaring failure in EU policy to pass unregarded, not when the UK’s approach (possible only because we have left the EU) has so far been a world-leader. |
Re: Coronavirus
Quote:
But what does annoy me is that the UK Minister, while giving categoric assurances this morning on TV, would not provide information to back his statement up. People here are very worried and need believable re-assurance. Btw, having a chuckle at the EU's difficulties is only natural for normal British people. |
Re: Coronavirus
The German Government has also now denied the 8% effectiveness story and I believe the newspaper has withdrawn the story.
https://www.reuters.com/article/us-h...-idUSKBN29V0ZC |
Re: Coronavirus
If you can't blame Boris, blame the EU/Brexit. If it's not EU/Brexit it's Boris.
More seriously though is the Oxford vaccine's ability to be stored more "normally" means it's the better choice in countries without the high tech infrastructure that we in the West have. If the German report is founded then it will have less impact in the West where we can use the other vaccines on older folk and the Oxford one where it is effective. --- On another line : how should centres use up spare vaccine that can't be stored when the booked appointments have been cleared? Not condoning queue jumping per se as reported friends using common link to get appointment but reports on media that stock of vaccine at end of day are being given to people further down priority where alternative is to bin it. (Assumes that stock isn't deliberately kept back) |
Re: Coronavirus
Quote:
Quote:
|
Re: Coronavirus
Quote:
The ‘international talent’ argument is irrelevant here. This is all about the fact that the EU’s inefficient procurement procedures have delayed the whole process. EU countries are all aware that Britain is streets ahead and it has not gone down well. They have yet even to approve the Astra Zeneca vaccine! This is the first example of the benefits of Brexit, and it’s only January. Having said that, I hope the problem at the Belgium operation is sorted out quickly. Lives are at stake here and so they need to get these problems resolved. |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
Quote:
|
Re: Coronavirus
Quote:
We had no option but to approve it because it's the only show in town. Even then we may not hit the herd immunity threshold with it. So I'd not count those chickens before they hatch. More lockdowns while we wait on more effective vaccines would be a sub-optimal outcome I'm sure you'd agree. |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
The UK regulator was satisfied that the vaccine is safe and while it did review the trial data it saw no reason there not to allow the vaccine to be used. Why the EMA feels it has to spend so much longer on it is anyone’s guess. I suspect it probably has more to do with the vendors and quantities the EU has purchased causing them to focus on approving other vaccines first (principally Pfizer, followed by Moderna), though even here, they haven’t exactly moved nimbly. Across the pond, the FDA has a long-established reputation for refusing to accept conclusions drawn from trial data as presented by drug companies and for conducting its own exhaustive reviews of raw data. Approving drugs always takes longer there as a result. |
Re: Coronavirus
@jonbxx
Jon - you might know the answer. Let's say that a CV sufferer of a couple of months tests positive at that point. That sufferer appears to be recovering. Some people are saying that although testing positive, the sufferer is no longer contagious. Is that right? Can the swab test differentiate between active and inactive virus cells? Logic tells me that whatever the sufferer is spewing out at that point would be contagion unless virus cells detected were inactive. Cheers. |
Re: Coronavirus
My point by “the only show in town” is we don’t have sufficient vaccine orders for any other vaccine to have a widespread vaccination programme with any other.
At no point am I suggesting it’s unsafe however there’s a clear “emergency use” rationale for us to approve it while others with a more diverse set of orders do not. I’d certainly be reluctant to claim victory in this race so early when the real world performance with 12 week gaps, and against mutant strains, is untested (I accept this is true of all vaccines). While it may be possible to drive up, based on a subset of results, the Ox/At vaccine to 90% that’s not the basis on which we are delivering it now. Emergency use can be issued where a regulator is satisfied it will have an effect better than doing nothing. Not necessarily that it’ll achieve herd immunity or equally perform to other products in the marketplace that you can’t buy anyway. |
Re: Coronavirus
Quote:
Quote:
|
Re: Coronavirus
It's worth noting that the UK is ahead of most countries (I think 3rd in the world) for vaccine distribution. So props to the NHS and Boris.
|
All times are GMT +1. The time now is 11:46. |
Powered by vBulletin® Version 3.8.11
Copyright ©2000 - 2024, vBulletin Solutions Inc.